Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
No Data
Update on FDA Priority Review of LEQEMBI IQLIK (Lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease
Eisai Posts 88 Billion Yen Leqembi Revenue For Fiscal 2025
Surging Leqembi Sales Boost BioArctic Royalties as Global Alzheimer's Rollout Expands
BioArctic Gains EUR 20 Million Milestone as Leqembi Sales Top EUR 500 Million
Biogen Trims Full-year Earnings Outlook on BD Impact
Eisai's E6742 Lupus Trial Advances: What ESALF Investors Need to Know